Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pramook, Phromratanapongse"'
Autor:
Pramook Phromratanapongse, Ladawan Narkwong, Sathit Ruangdilokrat, Pichai Ngampanprasert, Lak Sookpreedee, Vutisiri Veerasarn, Prasert Lertsanguansinchai, Poonkiat Rungpoka, Somphob Sangkittipaiboon, Sirisak Puribhat, Vicharn Lorvidhaya, Imjai Chitapanarux, Supatra Sangruchi, Thanatip Tantivatana, Supamitr Trithratipvikul, Chanawat Tesavibul, Chonlakiet Khorprasert, Yongyut Kongthanarat, Apichart Panichevaluk, Bannakij Lojanapiwat
Publikováno v:
Radiotherapy and Oncology. 73:179-185
Background and purpose To evaluate the efficacy and the safety of WF10 as adjunct to standard treatment in the management of late hemorrhagic radiation cystitis compared to standard treatment alone. Patients and methods Cervical cancer patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2de923e08f76c4a4943617399ce40a30
https://doi.org/10.1016/j.radonc.2004.05.007
https://doi.org/10.1016/j.radonc.2004.05.007
Autor:
Vicharn Lorvidhaya, Savitree Maoleekoonpairoj, Saipin Tangkaratt, Suwannee Sirilerttrakul, Pramook Phromratanapongse, Puangthong Kraipiboon, Pitayapoon Pattaranutaporn, Vorachai Ratanatharathorn, Vichien Srimuninnimit, Arkom Cheirsilpa
Publikováno v:
Lung Cancer. 31:257-265
We conducted a phase II trial to investigate the efficacy of concurrent chemoradiation in patients with stage III non-small-cell lung cancer (NSCLC). Thirty patients with inoperable NSCLC were enrolled onto a multicenter phase II trial of concurrent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f894858b48bafc8e1d7e7f7e7358234
https://doi.org/10.1016/s0169-5002(00)00171-9
https://doi.org/10.1016/s0169-5002(00)00171-9
Autor:
Vicharn, Lorvidhaya, Imjai, Chitapanarux, Pramook, Phromratanapongse, Pimkhuan, Kamnerdsupaphon, Ekkasit, Tharavichitkul, Prasert, Lertsanguansinchai, Chang-Yao, Hsieh, Vimol, Sukthomya
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(7)
The objective of this study is to evaluate the efficacy and safety of capecitabine in cervical cancer patients who have locoregional failure and/or distant metastasis and failed first line therapy. The efficacy of capecitabine is determined by the ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::421adc73f3830b2e0f0f39b80eb6e886
https://pubmed.ncbi.nlm.nih.gov/20647708
https://pubmed.ncbi.nlm.nih.gov/20647708
Autor:
Vutisiri, Veerasarn, Pramook, Phromratanapongse, Nan, Suntornpong, Vicharn, Lorvidhaya, Vimol, Sukthomya, Imjai, Chitapanarux, Chanawat, Tesavibul, Thiti, Swangsilpa, Cholakiet, Khorprasert, Kanjana, Shotelersuk, Yongyut, Kongthanarat, Apichart, Panichevaluk, Sunanta, Chiewvit, Pawana, Pusuwan, Monreudee, Aekmahachai, Samart, Ratchadara, Sasitorn, Sirilipoche, Yuttana, Saengsuda
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 89(12)
Amifostine has a potential role for salivary gland protection in head and neck cancer patients who had radiotherapy.Sixty-seven head and neck cancer patients were randomized to receive radiotherapy or radiotherapy plus Amifostine. The efficacy of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::402bc4a3175b37f59d59e5cbbdb73db9
https://pubmed.ncbi.nlm.nih.gov/17214057
https://pubmed.ncbi.nlm.nih.gov/17214057
Autor:
Vutisiri, Veerasarn, Pramook, Phromratanapongse, Vicharn, Lorvidhaya, Prasert, Lertsanguansinchai, Chawalit, Lertbutsayanukul, Apichart, Panichevaluk, Wiroon, Boonnuch, Vitoon, Chinswangwatanakul, Darin, Lohsiriwat, Arun, Rojanasakul, Parinya, Thavichaigarn, Paiboon, Jivapaisarnpong
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 89(11)
Phase I multicenter study defined the maximal tolerated dose (MTD), dose-limiting toxicity (DLT) and safety profile of capecitabine in combination with preoperative radiation for patients with locally advanced rectal cancer (LARC).Patients were treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::33c20b287bc40548b1b03b71530b2343
https://pubmed.ncbi.nlm.nih.gov/17205868
https://pubmed.ncbi.nlm.nih.gov/17205868
Autor:
Richard A. Steeves, Ronelle Moe, Bhudatt Pallwal, Pramook Phromratanapongse, Bruce R. Thomadsen, Siamak Shahabi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 19:239
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7029594a1597a4dc8b39d4e792d087fb
https://doi.org/10.1016/0360-3016(90)90869-l
https://doi.org/10.1016/0360-3016(90)90869-l
Publikováno v:
Archives of surgery (Chicago, Ill. : 1960). 124(12)
•One hundred twenty-two patients (124 tumor sites) with breast carcinoma (T1 to T3, N0 to N2, MO) were treated by a lumpectomy and radiation therapy at the University of Wisconsin, Madison, from June 1978 to December 1986. Irradiation to the breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dfc9ca80f3a32b2d9da355450164d33
https://pubmed.ncbi.nlm.nih.gov/2589959
https://pubmed.ncbi.nlm.nih.gov/2589959